Greg Caporaso, director of the Center for Applied Microbiome Science, part of the Pathogen and Microbiome Institute (PMI) at Northern Arizona University, has been awarded a $3.75 million grant by the National Cancer Institute (NCI) to build software capable of analyzing and archiving data focused on the interplay between the… Read more
The Pathogen and Microbiome Institute
Access the full Festival of Science program of events here.
Now in its 31st year, the award-winning annual Festival of Science—the longest-running event of its kind in the Western Hemisphere—continues to be a cornerstone event for the Flagstaff community, with Northern Arizona University playing a key role in the festival’s success. Through active participation by NAU scientists, artists and educators, as well as through a robust sponsorship commitment, the university contributes to the Flagstaff community through the festival in… Read more
Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona’s first reported case of COVID-19 in late January, the state experienced no subsequent cases that went undetected and was COVID-free until at least 11 distinct incursions occurred between mid-February and early April.
The published results appear in the scientific journal mBio.
Faculty at Northern Arizona University (NAU), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, University of Arizona (UArizona)… Read more
Scientists at two Northern Arizona University research centers—the Pathogen and Microbiome Institute (PMI) and the Center for Health Equity Research (CHER)—recently received grants totaling $175,000 from the Flinn Foundation in support of projects directed at responding to the COVID-19 threat.
Researchers in PMI are internationally recognized for their… Read more
C. Todd French, assistant professor of biology and leader of Northern Arizona University’s new COVID-19 Testing Service Center (CTSC), is working with scientists at Vault Pharma, an emerging biotechnology company, to test candidate vaccines against the novel coronavirus. Through a multi-institutional public-private partnership linking the company with UCLA, NAU and the University of Nebraska–Lincoln, French is… Read more
One of the most challenging aspects of the COVID-19 pandemic has been the lack of testing needed to detect and trace infections—and without adequate testing, government officials do not have the data they need to make the best possible decisions in the interest of public health.
In addition to being in short supply,… Read more